Exact Mass: 415.1563922
Exact Mass Matches: 415.1563922
Found 86 metabolites which its exact mass value is equals to given mass value 415.1563922,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
I-BET151
C23H21N5O3 (415.16443160000006)
Margrapine B
Margrapine B is found in citrus. Margrapine B is from roots of Marsh grapefruit (Citrus paradisi
Idelalisib
C22H18FN7O (415.15567899999996)
(+)-macrantoridine|2,3-dimethoxy-6-((R or S)-4-methoxy-6-methyl-5,6,7,8-tetrahydro-[1,3]dioxolo[4,5-g]isoquinolin-5-ylmethyl)-benzoic acid|Macrantoridin|Macrantoridine
Margrapine B
((((2-(6-AMINO-9H-PURIN-9-YL)ETHOXY)METHYL)(ETHOXY)PHOSPHORYL)OXY)METHYL PIVALATE
N-Methyl-N-(3-[((N-tert-butoxycarbonyl-N-methylamino)acetoxy)methyl]pyridin-2-yl)carbamic acid 1-chloroethyl ester
CAL-101
C22H18FN7O (415.15567899999996)
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EM - Phosphatidylinositol-3-kinase (pi3k) inhibitors C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C2152 - Phosphatidylinositide 3-Kinase Inhibitor C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor D000970 - Antineoplastic Agents D004791 - Enzyme Inhibitors
2-(2-methoxyphenyl)-N-[4-[5-(3-methoxyphenyl)-1,2,4-oxadiazol-3-yl]phenyl]acetamide
C24H21N3O4 (415.15319860000005)
2-[(chloroacetyl)(4-methoxyphenyl)amino]-N-cyclohexyl-2-pyridin-3-ylacetamide
C22H26ClN3O3 (415.1662596000001)
4-[2-[[1-(2-methoxyethyl)-2-benzimidazolyl]thio]-1-oxoethyl]-2,5-dimethyl-1H-pyrrole-3-carboxylic acid ethyl ester
C21H25N3O4S (415.15656900000005)
2-(2,4-dimethoxyphenyl)-N-[1-(2-furyl)ethylidene]-4-quinolinecarbohydrazide
C24H21N3O4 (415.15319860000005)
4-[(2,4-Dimethoxyanilino)methylidene]-2-(6-methyl-2-pyridinyl)isoquinoline-1,3-dione
C24H21N3O4 (415.15319860000005)
5-Carbamoyl-4-methyl-2-[[1-oxo-2-(1,2,3,4-tetrahydronaphthalen-1-ylamino)ethyl]amino]-3-thiophenecarboxylic acid ethyl ester
C21H25N3O4S (415.15656900000005)
2-Methyl-1-phenyl-5-benzimidazolecarboxylic acid [2-(2-methoxyanilino)-2-oxoethyl] ester
C24H21N3O4 (415.15319860000005)
(1S,17S,19S)-16,16-dimethyl-14-oxido-7,10,23,25-tetraza-14-azoniaheptacyclo[17.5.2.01,17.03,15.04,13.06,11.019,23]hexacosa-2,4,6,8,10,12,14-heptaene-24,26-dione
C23H21N5O3 (415.16443160000006)
(-)-noscapine hemiacetal
A lactol that is (-)-noscapine [which is also known as (-)-alpha-narcotine] in which the carbonyl group of the lactone moiety has been reduced to give the corresponding lactol. It is the biosynthetic precursor of (-)-noscapine.
BAY-179
C23H21N5OS (415.14667360000004)
BAY-179 is a potent, selective, and species cross-reactive complex I inhibitor (IC50=79 μM)[1].
n-[5-hydroxy-13,14,15-trimethoxy-4-(methoxycarbonyl)tricyclo[9.4.0.0²,⁷]pentadeca-1(15),2(7),3,5,11,13-hexaen-8-yl]ethanimidic acid
2-({[(2s,3r,4s,5r,6r)-3,5-dihydroxy-6-(hydroxymethyl)-4-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}methyl)-1-methyl-1-oxohydrazinium
(5r)-5-hydroxy-5-[(2r,3s)-4-hydroxy-7-methoxy-2,3,8-trimethyl-6,9-dioxo-2h-naphtho[1,2-b]furan-3-yl]-2-methylpent-2-enimidic acid
n-[(10r)-3,4,5,14-tetramethoxy-13-oxotricyclo[9.5.0.0²,⁷]hexadeca-1(16),2,4,6,11,14-hexaen-10-yl]methoxycarboximidic acid
6-(hydroxymethyl)-6,9a-dimethyl-3-oxo-1h,5h,5ah,7h,8h,9h,9bh-naphtho[1,2-c]furan-5-yl 4-nitrobenzoate
1-methyl-1-oxo-2-({[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}methyl)hydrazinium
(3r,3's)-3'-methoxy-1,3'-dimethyl-2'-[(1e)-2-phenylethenyl]spiro[indole-3,6'-pyrrolo[1,2-c]imidazole]-1',2,5'-trione
C24H21N3O4 (415.15319860000005)
2,3-dimethoxy-6-{[(5s)-4-methoxy-6-methyl-2h,5h,7h,8h-[1,3]dioxolo[4,5-g]isoquinolin-5-yl]methyl}benzoic acid
5-(2-{2-[2-(dimethylamino)ethyl]-4,5-dimethoxyphenyl}acetyl)-2h-1,3-benzodioxole-4-carboxylic acid
[(5r,5ar,6s,9ar,9br)-5-hydroxy-6,9a-dimethyl-3-oxo-1h,5h,5ah,7h,8h,9h,9bh-naphtho[1,2-c]furan-6-yl]methyl 4-nitrobenzoate
{5-hydroxy-6,9a-dimethyl-3-oxo-1h,5h,5ah,7h,8h,9h,9bh-naphtho[1,2-c]furan-6-yl}methyl 4-nitrobenzoate
5-hydroxy-5-{4-hydroxy-7-methoxy-2,3,8-trimethyl-6,9-dioxo-2h-naphtho[1,2-b]furan-3-yl}-2-methylpent-2-enimidic acid
(5r,5ar,6s,9ar,9br)-6-(hydroxymethyl)-6,9a-dimethyl-3-oxo-1h,5h,5ah,7h,8h,9h,9bh-naphtho[1,2-c]furan-5-yl 4-nitrobenzoate
16,18,19-trimethoxy-13-methyl-5,7,22-trioxa-13-azapentacyclo[12.8.0.0²,¹⁰.0⁴,⁸.0¹⁵,²⁰]docosa-2,4(8),9,15,17,19-hexaen-21-ol
6-[(s)-hydroxy[(5r)-4-methoxy-6-methyl-2h,5h,7h,8h-[1,3]dioxolo[4,5-g]isoquinolin-5-yl]methyl]-2,3-dimethoxybenzaldehyde
(3s)-6,7-dimethoxy-3-[(5r)-4-methoxy-6-methyl-2h,5h,7h,8h-[1,3]dioxolo[4,5-g]isoquinolin-5-yl]-1,3-dihydro-2-benzofuran-1-ol
(2e,5r)-5-hydroxy-5-[(2r,3s)-4-hydroxy-7-methoxy-2,3,8-trimethyl-6,9-dioxo-2h-naphtho[1,2-b]furan-3-yl]-2-methylpent-2-enimidic acid
3'-methoxy-1,3'-dimethyl-2'-(2-phenylethenyl)spiro[indole-3,6'-pyrrolo[1,2-c]imidazole]-1',2,5'-trione
C24H21N3O4 (415.15319860000005)